Login / Signup

Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer.

Philip C MackChih-Yuan HsuAnanda M RodillaJorge E GomezJazz CaganYuanhui HuangSooyun Caroline TavolacciRajesh M ValanparambilNicholas RohsRachel BrodyBrittney NicholsJuan Manuel CarreñoSheena BhallaChristian RolfoDavid E GerberAmy MooreJennifer C KingRafi AhmedJohn D MinnaPaul A BunnAdolfo García-SastreFlorian KrammerFred R HirschYu Shyr
Published in: Vaccines (2024)
In patients with lung cancer (LC), understanding factors that impact the dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) anti-spike antibody (SAb) titers over time is critical, but challenging, due to evolving treatments, infections, vaccinations, and health status. The objective was to develop a time-dependent regression model elucidating individual contributions of factors influencing SAb levels in LC patients using a prospective, longitudinal, multi-institutional cohort study initiated in January 2021. The study evaluated 296 LC patients-median age 69; 55% female; 50% stage IV. Blood samples were collected every three months to measure SAb levels using FDA-approved ELISA. Asymptomatic and unreported infections were documented through measurement of anti-nucleocapsid Ab levels (Meso Scale Discovery). Associations between clinical characteristics and titers were evaluated using a time-dependent linear regression model with a generalized estimating equation (GEE), considering time-independent variables (age, sex, ethnicity, smoking history, histology, and stage) and time-dependent variables (booster vaccinations, SARS-CoV-2 infections, cancer treatment, steroid use, and influenza vaccination). Significant time-dependent effects increasing titer levels were observed for prior SARS-CoV-2 infection ( p < 0.001) and vaccination/boosters ( p < 0.001). Steroid use ( p = 0.043) and chemotherapy ( p = 0.033) reduced titer levels. Influenza vaccination was associated with increased SAb levels ( p < 0.001), independent of SARS-CoV-2 vaccine boosters. Prior smoking significantly decreased titers in females ( p = 0.001). Age showed no association with titers. This GEE-based linear regression model unveiled the nuanced impact of multiple variables on patient anti-spike Ab levels over time. After controlling for the major influences of vaccine and SARS-CoV-2 infections, chemotherapy and steroid use were found to have negatively affected titers. Smoking in females significantly decreased titers. Surprisingly, influenza vaccinations were also significantly associated, likely indirectly, with improved SARS-CoV-2 titers.
Keyphrases